IBEXITEP
Live / Applied — First extension granted (statement of use) (as of 04 Dec 2025)
What this means for you
Not registered yet, but its 13 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98851187
- Mark type
- Stylized text
- Filed
- 13 Nov 2024
- Published for opposition
- 27 May 2025
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of respiratory, inflammatory, and immunological diseases and disorders; pharmaceutical preparations for the prevention and treatment of chronic obstructive pulmonary disease (COPD).
Owner
- Sanofi Biotechnology, Gentilly, FR
- Sanofi Biotechnology, Gentilly, FR
Prosecution history
- 05 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Dec 2025 — SOU EXTENSION 1 GRANTED
- 04 Dec 2025 — SOU EXTENSION 1 FILED
- 04 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 May 2025 — PUBLISHED FOR OPPOSITION
- 21 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Apr 2025 — ASSIGNED TO EXAMINER
- 13 Nov 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED